Copeland Capital Management LLC Has $25.74 Million Holdings in iRadimed Corporation (NASDAQ:IRMD)

Copeland Capital Management LLC lifted its position in iRadimed Corporation (NASDAQ:IRMD - Free Report) by 3.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 490,544 shares of the medical equipment provider's stock after buying an additional 14,981 shares during the quarter. Copeland Capital Management LLC owned about 3.86% of iRadimed worth $25,744,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in iRadimed by 4.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,577 shares of the medical equipment provider's stock valued at $252,000 after acquiring an additional 204 shares during the last quarter. Albert D Mason Inc. raised its holdings in shares of iRadimed by 2.0% during the 1st quarter. Albert D Mason Inc. now owns 17,269 shares of the medical equipment provider's stock valued at $906,000 after purchasing an additional 333 shares in the last quarter. Bessemer Group Inc. lifted its stake in shares of iRadimed by 9.6% in the 4th quarter. Bessemer Group Inc. now owns 4,143 shares of the medical equipment provider's stock valued at $228,000 after purchasing an additional 362 shares during the last quarter. Bridge City Capital LLC boosted its holdings in iRadimed by 0.8% in the fourth quarter. Bridge City Capital LLC now owns 61,899 shares of the medical equipment provider's stock worth $3,404,000 after purchasing an additional 462 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its holdings in iRadimed by 2.3% in the fourth quarter. BNP Paribas Financial Markets now owns 21,138 shares of the medical equipment provider's stock worth $1,163,000 after purchasing an additional 477 shares in the last quarter. Institutional investors own 92.34% of the company's stock.

iRadimed Stock Up 0.2%

IRMD stock traded up $0.13 during midday trading on Friday, hitting $60.84. 188,754 shares of the company traded hands, compared to its average volume of 44,459. iRadimed Corporation has a twelve month low of $42.34 and a twelve month high of $63.29. The business has a 50 day simple moving average of $55.57 and a 200-day simple moving average of $55.24. The stock has a market capitalization of $773.88 million, a price-to-earnings ratio of 39.25 and a beta of 0.92.

iRadimed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend was Tuesday, May 20th. iRadimed's dividend payout ratio (DPR) is 43.87%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised iRadimed from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, May 6th.

iRadimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.